ctDNA Testing Is Poised to Reshape Risk Assessment and Treatment Decision-Making in Bladder Cancer.
Saved in:
| Title: | ctDNA Testing Is Poised to Reshape Risk Assessment and Treatment Decision-Making in Bladder Cancer. |
|---|---|
| Authors: | DOHERTY, KYLE |
| Source: | OncologyLive. May2026, Vol. 27 Issue 5, p18-22. 4p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
